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Abstract: Mucopolysaccharidosis type IVA or Morquio A syndrome is characterized by the lack of
N-acetylgalactosamine-6-sulfate-sulfatase and the accumulation of keratan sulfate and chondroitin-6-sulfate in the
lysosomes. At least, 148 mutations and 16 polymorphisms were identified in the GALNS gene.
The aim of this study was the screening of polymorphisms within 7 patients recruited from many regions of
Tunisia in order to determine the haplotypes and their association with the mutations previously reported.
Patients and methods: We have used the PCR sequencing to analyse the different haplotypes and to identify the
polymorphisms within 7 affected MPS IVA patients.
Results: Nine GALNS polymorphisms were detected in the 7 studied patients. Five of these polymorphisms are
within the GALNS gene exons. Six polymorphisms have been previously described and used for linkage analysis in
MPS IVA patients and determination of haplotypes. We have identified two novel heterozygous polymorphisms in
intron 13 and intron 3
Conclusion: Polymorphisms may be useful for carrier detection and prenatal diagnosis in informative families
whose specific mutations have not been identified. The determination of haplotypes can also determine the origin
of some mutations in a population.
Background
Mucopolysaccharidosis IVA (Morquio A syndrome;
MPS IVA) is an autosomal recessive disease that is clas-
sified in the group of mucopolysaccharide storage dis-
eases. It results from a deficiency of the lysosomal
enzyme N-acetylgalactosamine-6-sulfate sulfatase
(GALNS; E.C.3.1.6.4) [1], which hydrolyses N-acetylga-
lactosamine-6-sulfate and galactose-6-sulfate in glycosa-
minoglycans. GALNS deficiency causes intralysosomal
accumulation and urinary secretion of undegraded kera-
tane sulfate (KS) and chondroitine-6-sulfate (C6S).
Phenotypes in Morquio A disease vary from the classical
form with severe bone dysplasia, heart valve involvement,
corneal opacity, short trunk dwarfism and a life span of 20
to 30 years, to attenuated forms with normal life span,
mild bone involvement and mild visceral organ involve-
ment. Unlike the other forms of mucopolysaccharidoses,
Morquio A disease is characterized by normal intelligence.
Investigations of the allelic heterogeneity in MPS IVA
have been facilitated by the isolation and characteriza-
tion of the full length cDNA encoding the human
GALNS protein and the genomic GALNS gene [2]. The
GALNS gene spans 35 kb in length, contains 14 exons
and 13 introns, and was mapped to the region 16q24, by
in situ hybridization [3]. To date, multiple mutations
responsible for various clinical phenotypes of MPS IVA
have been described [4]. Sixteen polymorphisms have
been also detected in the GALNS gene [5-7]. Some
polymorphisms were used for the haplotype analysis.
In the present paper, we have screened the GALNS
gene of 7 affected MPS IVA patients using genomic
DNA samples and performing polymerase chain reaction
(PCR) in combination with DNA sequence analysis.
Patients and methods
Patients
The study was carried out on 7 MPS IVA patients
recruited in paediatric departments of different geographic
areas of Tunisia (Central and Southern areas). It was
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Tunisian hospitals, and the families gave informed consent
before withdrawal of blood.
Family and history description of the 7 studied
patients were summarized in table 1.
T h ep a t i e n t sw e r ea l w a y sc o n s a n g u i n e o u sb u tt h e
families completely unrelated to each other and lived far
apart. All the affected children have healthy sibling(s).
Patients 1 - 2 and 3 - 4 belong to the same siblings.
Patients 1
He was the second child of healthy first degree consan-
guineous parents originated from the South of Tunisia
and no skeletal disorders had occurred in the family. The
patient was delivered vaginally after an uncomplicated
full-term pregnancy. He was eutrophic at birth and dur-
ing the first year of life, psychomotor and mental charac-
teristics were perfectly normal. From 18 months of age,
he had progressive walking troubles with tendency to fall.
At the age of 3 years, he has been operated for inguinal
hernia. The surgeon revealed osseous malformations
such as genu valgum, dorsal and lumbar cyphosis. At the
age of 9 years, he wore an orthopedic corset without any
result. Marked bone dysplasias (sternal bulge, dispropor-
tional dwarfism with short trunk and neck) with arthro-
chalasis associated with functional troubles and facial
dysmorphism (peg shaped dentition, head rejection) led
to the diagnosis of Morquio A syndrome.
Radiologic examination detected skeleton malforma-
tions on cervical rachis (flat cervical vertebra, hypoplasia
of the odontoid apophysic second vertebrae), on thorax
(oar-appearing ribs) and rachis. The ophtalmological
examination was normal. Morquio A syndrome was
based on findings of keratansulfaturia and very low level
of GALNS activity in leukocytes. At the age of 15 years,
the examination of the patient highlighted important
osseous deformations and abdominal distension without
spanchnomegalia. The neurological examination was
normal. He was doing excellently in the high school,
especially in maths and physics although many practical
problems such as speed of writing, transportation as he
still could barely walk. During the survey, we could ask
for an electric handicapped adapted car to allow him to
go to school easier. The patient’sp h e n o t y p ew a sc l a s s i -
cal Morquio A disease, severe form.
Patient 2
This girl of 2 years, the sibling case of patient 1 was
asymptomatic when MPS IVA was confirmed by enzy-
matic assay with a very low GALNS activity. The vaginal
delivery and the postnatal period were without any com-
plication. Since then, the patient has developed gradually
scoliosis, pectus carinatum and severe valgus deformi-
ties. She was intellectually normal but had quickly
decreased motor function and barely walked from the
age of 5 years, and finally could not go to school, con-
trary to her brother. One year later, a spastic paraplegia
occurred. Cervical MRI showed a cervical spine com-
pression. After performing surgery stabilizing the upper
cervical spine, she had partially recovered.
Patient 3
Patient 3 appeared perfectly normal at birth after vaginal
delivery. His father was married with his cousin’s daugh-
ter. At the age of 3 years, the patient had a waddling
gate with a tendency to fall, that required medical stu-
dies at paediatric unit of Kairouan hospital (central
Tunisia). Marked growth retardation, facial dysmorph-
ism with a particular protrusion, bone dysplasias, short
trunk and neck, sternal bulge, disproportional dwarfism
led to the clinical diagnosis of Morquio syndrome. Kera-
tane sulfaturia was detected and enzyme assay revealed
MPS IVA. At the age of 8 years, further skeletal X-rays
investigation typically showed marked flattening of the
vertebra, oar-appearing ribs, cyphosis with generalized
platyspondylia. Cardiac examination detected and left
ventricular hypertrophy.
Neurological investigation was normal in spite a rela-
tive retardation in school performances which may be
explained by hearing impairment.
Patient 4
she had no symptom except slight thoracic deformation
when she was studied at 16 months because of the dis-
ease in her brother, patient 3. Biochemical investigations
detected keratosulfaturia and a very low level of GALNS
Table 1 Description of the 7 MPS IVA patientsyr: years, mo: months
Features Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
Consanguinity of the parents/degree 1st degree 1st degree 3rd degree 3rd degree 1st degree 1st degree 1st degree
Age of diagnosis (yr/mo) 3 8 3 5/4 4/5 7/7 7
Age of onset (yr/mo) 18 months 14 months 2 16 months 2/3 18 mo 3
Sex Male Female Male Female Female Female Female
Age (yr/mo) 15 13 9/8 8 11/7 Died at 7yr 14
Height cm (SD) 1 m (-4.8) 96 (-6) 95 (-5.9) 90 (-6.6) 96 (-8.4) 98 (-5) 122 (-4)
Weight kg (SD) 17 (-3.2) 14 (-3.3) 16 (-3.1) 15 (-2.3) 16 (-3) 15 (-2.3) 26 (-2.3)
GALNS assay (nmoles/h/mg prot) 0.04 0.02 0.03 Not done 0.005 0.06 0.07
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Page 2 of 5activity, leading to Morquio A syndrome. She was trea-
ted surgically for tibia osteotomy because of an intense
genu valgum which avoided her to walk. Then, the clini-
cal course was similar to her brother’s. Gradually, facial
dysmorphim and disproportional dwarfism developed.
At the age of 5 years, radiographs detected truncal dys-
morphim and dorsal-lumbar cyphosis with generalized
platyspondylia. Intellectually, the patient was normal
and doing well at school.
Patient 5
This little girl whose parents were first cousin was the
first child, after a normal vaginal delivery. At the age of
4 years, she was referred to paediatric Unit of Kairouan
Hospital (Central Tunisia) for medical investigation of
severe dysmorphic syndrome.
Retrospectively, the onset of the disease could be
ascertained to 2 years of age with abnormal prominence
of the breastbone. Gradually, valgus deformities of the
knees, funnel like chest with carinate pectus developed
associated with characteristic facial appearance (broad
mouth, small nose) and abnormal flexibility of joints.
The Morquio A diagnosis was confirmed by keratansul-
faturia and deficient activity of GALNS in leukocytes. By
the age of 8 years, compensatory upper thoracal lower
thoraco-lumbar scoliosis and cervicothoracal cyphosis
developed. They resulted in progressive shortening of
the walking distance and fatigue. Skeletal radiographs
showed severe dysostosis, generalized platyspondylia,
and important anterior hypoplasia of L1. Cervical MRI
indicated compression of the medulla.
Aspastic paraplegia occurred by the age of 10 years
and the surgeons refused to perform any operation.
Now, hepatomegaly, mitral insufficiency and cornal
clouding have developed. Her severe handicap avoided
h e rt og ot os c h o o l ,a l t h o u g hh e ri n t e l l i g e n c ew a sp r e -
served. In addition, very low socio economical condi-
tions result in extremely bad conditions of life for the
child and the whole family.
Patient 6
S h ew a st h et h i r dc h i l db o r nt oconsanguineous family,
after a normal vaginal delivery. By the age of 18 months,
this child was evaluated for growth failure, feel walking
problems and intensive genu valgum at paediatric
department of Sidi Bouzid Hospital in central Tunisia.
Associated with facial dysmorphism (protrusion of lower
facial maxillary) but normal dentition, the trunk was
short and pectus carinatum was observed. She was diag-
n o s e da sM P SI V Ao nt h eb a s i so fc l i n i c a la n a l y s i sa n d
the diagnosis was demonstrated by biochemical analysis
(keratansulfaturia and no detectable activity of GALNS
in leukocytes).
At the age of 7 years, skeletal X-rays and cervical
magnetic resonance imaging (MRI) typically showed
acute osseous deformation with dorsal and lumbar
cyphosis. The vertebra was markly flattening and the
connection between first and second vertebra in the
neck was extremely poorly developed with a compres-
sion of the bulbospinal region. Her intelligence was nor-
mal and she was studying well at the first year of
school. The overall physical handicap was severe and
she eventually died few days after spinal deformity surgi-
cal treatment, during the molecular study.
Patient 7
She was the third child born to consanguineous family
and she had 2 MPS IVA unaffected brothers. By the age
of 3 years, this girl was referred to paediatric unit of
Tunis (north of Tunisia). She was evaluated for facial
dysmorphism, protrusion, bone dysplasias, short trunk
and neck, sternal bulge and disproportional dwarfism.
At the age of 7 years, skeletal X-rays and cervical mag-
netic resonance imaging (MRI) typically showed acute
osseous deformation with dorsal and lumbar cyphosis.
By the age of 11 years, radiologic examination detected
skeleton malformations on cervical rachis (flat cervical
vertebra, hypoplasia of the odontoid apophysic second
vertebrae), on thorax (oar-appearing ribs) and rachis.
Cardiac examination was normal. Her intelligence was
normal and she was studying well at school.
Methods
PCR reactions allow detection of polymorphisms in GALNS
gene. The conditions were described previously [8].
For GALNS haplotyping, the mutant and normal
alleles were tested for six polymorphisms by PCR
sequencing [8]. The first polymorphism is within the
fifth intron (IV5+134; CCAAGG [allele A] or CCGAGG
[allele a]) [9]. The second polymorphism is located
within exon 7 (GCACGC [alleleB] or GCATGC
[allele b] [10]. The third polymorphism is positioned
within the seventh intron (IVS7nt90; GTAC [allele H]
or GAAC [allele h]. The fourth polymorphism is posi-
tioned within exon 11 (GTCC [allele C] or GGCC [allele
c]). The fifth polymorphism is located within the exon
13 (AAGCCT [allele D] or AGGCCT [allele d] [9]. The
sixth polymorphism (CCAG [allele E] or CCGC
[allele e] is located within the exon 14 [11].
Results
Nine GALNS polymorphisms were detected in the 7
studied patients (table 2). Of these polymorphisms, five
are within GALNS gene exons. Six polymorphisms (2, 3,
6, 7, 8, and 9) have been previously described and used
for linkage analysis in MPS IVA patients and determina-
tion of haplotypes.
The previous studies [8,12] showed that patients 1, 2,
3, 4 and 5 present the IVS1+1G-A homozygous muta-
tion while patient 6 present the G66R homozygous
mutation.
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tion occurred in the haplotype A/B/c/d/e/H. The haplo-
type associated with the G66R mutation was A/b/c/D/e/
h. The haplotype detected within patient 7 with A85T
mutation was A/b/C/d/E/H.
We have summarized the haplotypes associated with
mutations detected within the 7 studied patients in table 3.
We have identified two novel heterozygous poly-
morphisms in intron 13 and intron 3 (IVS13 + 75T-A
and IVS3 + 684C-A) within patient 7. These poly-
morphisms were identified within the normal Tunisian
population.
The other polymorphisms identified within patients 1,
2, 3, 4, 5 and 6 were previously reported.
Discussion
Morquio A disease is due to the lack of N-acetylgalactosa-
mine-6-sulfate-sulfatase. These deficiencies result in a pro-
gressive accumulation of the keratane sulfate. This process
leads to progressive and chronic course for visceral attacks
of the affected organs such as lungs and heart.
The molecular basis of GALNS deficiency leading to
the clinical symptoms of Morquio A disease is of parti-
cular interest because of its allelic heterogeneity, clinical
variability, and the presence of the common mutation
characteristic for each ethnic population.
Polymorphisms may be useful for carrier detection
and prenatal diagnosis in families whose specific muta-
tions have been identified.
The screening of polymorphisms in GALNS gene
revealed that there are at least 16 polymorphisms
detected [4]. Here, we describe two novel polymorph-
isms in intron 13 and intron 3 within patient 7. These
polymorphisms are in the heterozygous status.
Associations between a specific mutation and a speci-
fic haplotype can be demonstrated in genetic disorders.
To understand the origin of a mutation, it is very useful
to identify whether a certain recurrent mutation is asso-
ciated with the same haplotype. A frequent mutation
can be explained by the founder effect [13].
Haplotyping of known GALNS polymorphisms
revealed that the splice site mutation was on a common
background which suggests that these mutant alleles
were “identical by descent” and were derived from a
common ancestor.
Individuals resulting from a common ancestor are
likely to have inherited both copies of the mutated gene
and also in the haplotypes which will be transmitted to
descent [14] and thus rare genotypes are maintained.
Further screening in Tunisian population of haplotyp-
ing data for the splicing mutation IVS1+1G-A should
reveal whether this mutation is common in Tunisian
population because of a founder effect. Others screening
were also necessary for the analysis of the haplotypes
identified within patients 6 and 7.
The frequent haplotype identified in normal indivi-
duals is a/b/h/c/D/E [13]. This haplotype was not
detected within any one from the patients of this study.
The identification of polymorphisms and mutations in
the GALNS gene significantly promoted the understand-
ing of correlation with genotype and phenotype within
MPS IVA patients.
The identification of polymorphisms within the 7 stu-
died patients may provide means for prenatal diagnosis
for MPS IVA families.
Table 2 GALNS gene polymorphisms in Tunisian patients
Polymorphisms Patients Amino acid Nucléotide Exon/intron
1 Patient 6 L67M CTG > ATG Exon 2
2
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 H236H CAC > CAT Exon 7
3
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 E477E GAG > GAA Exon 13
4 Patient 7 IVS13+75T-A* GTG > GAG Intron 13
5 Patient 7 IVS3+684C-A* AAC > ACC Intron 3
6
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 - A > G Intron 5
7
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 - A > T Intron 7
8
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 A393S GCC > TCC Exon 11
9
a Patient 1, patient 2, patient 3, patient 4, patient 5, patient 6, patient 7 - A > G Exon 14
*Novel polymorphisms; a: polymorphisms used for haplotypes determination.
Table 3 Haplotypes and mutations detected within the
studied patients
Patients Haplotypes Mutations
1 A/B/c/d/e/H IVS1+1G-A Exon 1
2 A/B/c/d/e/H IVS1+1G-A Exon 1
3 A/B/c/d/e/H IVS1+1G-A Exon 1
4 A/B/c/d/e/H IVS1+1G-A Exon 1
5 A/B/c/d/e/H IVS1+1G-A Exon 1
6 A/b/c/D/e/h G66R Exon 2
7 A/b/C/d/E/H A85T Exon 3
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Screening of polymorphisms in GALNS gene and deter-
mination of the haplotypes is necessary to search the
origin of mutations within MPS IVA patients or to pro-
vide means for prenatal diagnosis if the mutation is
undefined.
To understand the origin of a mutation, it is very use-
ful to identify whether a certain recurrent mutation is
associated with the same haplotype.
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